Cas:42233-29-4 Tetradecanyl tricosanoate manufacturer & supplier

We serve Chemical Name:Tetradecanyl tricosanoate CAS:42233-29-4 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

Tetradecanyl tricosanoate

Chemical Name:Tetradecanyl tricosanoate
CAS.NO:42233-29-4
Synonyms:Tetradecanyl tricosanoate
Molecular Formula:C37H74O2
Molecular Weight:550
HS Code:

Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:
Exact Mass:
LogP:

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like Tetradecanyl tricosanoate chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Tetradecanyl tricosanoate physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Tetradecanyl tricosanoate Use and application,Tetradecanyl tricosanoate technical grade,usp/ep/jp grade.


Related News: Onconova Therapeutics, Inc. and Inceptua Medicines Access (a business unit of the Inceptua Group) recently announced they have entered into a collaboration to make available intravenous rigosertib via a Pre-approval Access Program in selected countries around the world. Tetradecanyl tricosanoate manufacturer A new case of coronavirus has been reported in the United Arab Emirates, the country’s fifth, the Ministry of Health and Prevention announced on Saturday. Tetradecanyl tricosanoate supplier Indonesia is suspending its visa-free travel for Chinese citizens and barring passengers who have visited mainland China in the past 14 days. Tetradecanyl tricosanoate vendor A new case of coronavirus has been reported in the United Arab Emirates, the country’s fifth, the Ministry of Health and Prevention announced on Saturday. Tetradecanyl tricosanoate factory Featured APIs: Production capacity continues to expand, targeted patents expire. Original research drugs: industry entry barriers are high, performance stability and certainty are high.